tiprankstipranks
Advertisement
Advertisement

China Life Insurance Sets March Board Meeting to Approve 2025 Results and Final Dividend

Story Highlights
  • China Life Insurance will hold a board meeting on 25 March 2026 to approve 2025 annual results.
  • The board will consider recommending a final dividend, signaling key decisions on capital returns to shareholders.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
China Life Insurance Sets March Board Meeting to Approve 2025 Results and Final Dividend

Meet Samuel – Your Personal Investing Prophet

China Life Insurance Co ( (HK:2628) ) just unveiled an announcement.

China Life Insurance Company Limited has scheduled a board meeting for 25 March 2026 to review and approve its audited financial results for the year ended 31 December 2025. The board will also consider a proposal for a final dividend and address other corporate matters, a step that will be closely watched by investors for signals on the insurer’s financial performance, capital management, and shareholder returns.

The most recent analyst rating on (HK:2628) stock is a Buy with a HK$40.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.

More about China Life Insurance Co

China Life Insurance Company Limited is a major life insurer incorporated in the People’s Republic of China and listed in Hong Kong. The company operates in the life insurance sector, providing a range of insurance and related financial products to individuals and institutions, with its shares traded under stock code 2628 on the Hong Kong Stock Exchange.

Average Trading Volume: 66,646,867

Technical Sentiment Signal: Buy

Current Market Cap: HK$1218.8B

For a thorough assessment of 2628 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1